Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Metagenomic Sequencing Market Expected To Grow In Terms Of Size?

The market size for metagenomic sequencing has experienced a fast-paced expansion in the past few years. The market, which was valued at $2.13 billion in 2024, is projected to reach $2.5 billion by 2025, with a compound annual growth rate (CAGR) of 17.2%. This significant surge during the historic period can be ascribed to factors such as increased government participation, a rising number of metagenome sequencing research projects, the growing use of metagenomics in genomics and diagnostic studies, availability of funds for research, and the emergence of Next Generation Sequencing (NGS) data analysis tools.

Rapid expansion is anticipated in the metagenomic sequencing market in the upcoming years, with a projected rise to $4.54 billion in 2029 and a compound annual growth rate (CAGR) of 16.1%. This anticipated surge can be linked to factors such as lower computational expenditures, heightened interest in the discovery of novel biomolecules, increasing use of advanced sequencing strategies, rise in demand for personalized medical treatments and disease detection, along with a surge in infectious illnesses. Key trends predicted for the future include cutting-edge technologies, the use of sophisticated genomic technologies in metagenomics, increased funding for research and development, sequencer technology advancements, and the usage of big data for NGS data analysis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

Which Key Factors Are Fueling Growth In The Metagenomic Sequencing Market?

An increased occurrence of infectious diseases is anticipated to boost the metagenomic sequencing market’s expansion. These diseases, caused by harmful micro-organisms such as viruses, bacteria, fungi, or parasites, can be transmitted, directly or indirectly, amongst individuals. The growing occurrence of conditions that destabilize the immune system, such as HIV/AIDS, treatments for cancer and autoimmune disorders, may make individuals more prone to infectious diseases. Metagenomic sequencing provides a robust, adaptable strategy for examining infectious diseases, offering critical perspectives into microbial diversity, patterns of transmission, resistance to antimicrobials, and monitoring of outbreaks. For example, in January 2023, the Government of Canada reported that 135 and 159 rabies samples were submitted in October and November 2022, respectively. Moreover, in March 2023, the US Centers for Disease Control and Prevention reported a 5.9% rise in TB cases in the US, increasing from 7,874 in 2021 to 8,331 in 2022. Hence, the increasing occurrence of infectious diseases is propelling the growth of the metagenomic sequencing market.

How Is The Metagenomic Sequencing Market Categorized Across Applications And Types?

The metagenomic sequencingmarket covered in this report is segmented –

1) By Product And Service: Reagents And Consumables; Instruments; Sequencing Services; Analysis And Data Interpretation Solutions

2) By Technology: 16S Rrna Sequencing; Shotgun Metagenomic Sequencing; Whole-Genome Sequencing And De Novo Assembly; Metatranscriptomics

3) By Application: Clinical Diagnostic; Environmental Remediation; Gut Microbe Characterization; Drug Discovery; Biofuel; Agriculture; Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits; Library Preparation Kits; Sequencing Kits; PCR And qPCR Reagents; Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS); Third-Party Sequencers; Microarrays; Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS); 16S rRNA Sequencing; Shotgun Metagenomic Sequencing; Amplicon Sequencing; Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software; Cloud-Based Data Analysis Services; Data Storage Solutions; Custom Analysis Tools; Data Interpretation Platforms

How Are Industry Trends Steering The Expansion Of The Metagenomic Sequencing Market?

Key players in the metagenomic sequencing industry are concentrating on service innovation to increase accuracy, throughput, and cost efficiency in sequencing. This type of service utilizes state-of-the-art genomic technologies capable of sequencing larger DNA fragments, thereby offering a more detailed overview of genetic structures than conventional short-read techniques. For example, Clinical Microbiomics A/S, a biotech organization based in Denmark, rolled out revolutionary long-read sequencing services in April 2024. These services, including 16S, ITS, 18S rRNA, bespoke gene sequencing, and extensive genomics and metagenomics, provide unrivalled resolution and quality in microbial examination. They enrich the understanding of microbial communities and aid in the development of top-quality metagenome-assembled genomes.

Which Firms Are Making The Biggest Impact In The Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Region Holds The Greatest Opportunity For Metagenomic Sequencing Market Expansion?

North America was the largest region in the metagenomic sequencing market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16117&type=smp

Browse Through More Reports Similar to the Global Metagenomic Sequencing Market 2025, By The Business Research Company

Metagenomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Clinical Oncology Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model